Impact of type 2 diabetes mellitus on acute levodopa responsiveness in Parkinson's disease: A Multicenter retrospective study
Olga Stockmann, Lan Ye, Carsten Buhmann, Fabian Maass, Christoph van Riesen, Christiane Weinrich, Florian Wegner, Matthias Höllerhage, Monika Pötter-Nerger, Martin Klietz · 2026
Read Impact of type 2 diabetes mellitus on acute levodopa responsiveness in Parkinson's disease: A Multicenter retrospective study by Olga Stockmann, Lan Ye, Carsten Buhmann, Fabian Maass, Christoph van Riesen, Christiane Weinrich, Florian Wegner, Matthias Höllerhage, Monika Pötter-Nerger, Martin Klietz (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13627794.txt.
Description
Olga Stockmann and co-authors test, in a 2026 study, if type 2 diabetes dulls the fast reply to levodopa in Parkinson's disease. The sugar ill oft rides with the nerve ill and may shape its course. The team read back files of 136 patients at three German centers. Each had a set levodopa test dose, with move scores read off and on the drug. Groups split by sugar state: sound, pre-diabetes, and full diabetes. Whole and part move replies were clashed across the three.
No clear split stood in the drug's pull. One gap showed: rest shake ran worse in the sugar group off drug. On drug, that gap shut, as their gain ran high. A long-run clash is the next ask.
Catalog record
| CREATOR | Olga Stockmann, Lan Ye, Carsten Buhmann, Fabian Maass, Christoph van Riesen, Christiane Weinrich, Florian Wegner, Matthias Höllerhage, Monika Pötter-Nerger, Martin Klietz |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |